Cumulase denudation
OtherTesting the effect of cumulase for women with poor oocyte yield due to poor ovarian reserve
NCT Number: NCT03778736
The cumulus-corona-oocyte complex (COCs) surrounds each oocyte and must be removed prior to intracytoplasmic sperm injection (ICSI). This is traditionally achieved with a bovine-derived hyaluronidase followed by mechanical denudation through pipetting. A human recombinant hyaluronidase (Cumulase) has been developed to circumvent the problems and concerns associated with the animal origin and lack of purity of the bovine-derived form of the enzyme. whether cumulase offers a higher chance for success after ICSI for women with 8 COCs or lower remains an open question.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Qena Fertility Center, Qina, Qena Governorate, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Testing the effect of cumulase for women with poor oocyte yield due to poor ovarian reserve
Time frame: 16 weeks
Continued pregnancy after 12 weeks of gestation
Time frame: Two weeks
Positive b-hCG at two weeks or more after embryo transfer
Time frame: 7 weeks
Detection of gestational sac with a heartbeat on ultrasound at 7 weeks of gestation
Time frame: 6 days of culture
fertilized oocytes per injected oocytes and developed embryos per fertilized oocytes
Ibn Sina Hospital
Other Gov
Can Cumulase Reduce the Shear Stress During Denudation for ICSI Cycles of ≤ 8 Cumulus-oocytes Complexes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details